The global and national burden of chronic kidney disease attributable to ambient fine particulate matter air pollution: a modelling study
Open Access
- 29 February 2020
- journal article
- research article
- Published by BMJ in BMJ Global Health
- Vol. 5 (3), e002063
- https://doi.org/10.1136/bmjgh-2019-002063
Abstract
Introduction We aimed to integrate all available epidemiological evidence to characterise an exposure-response model of ambient fine particulate matter (PM2.5) and the risk of chronic kidney disease (CKD) across the spectrum of PM2.5 concentrations experienced by humans. We then estimated the global and national burden of CKD attributable to PM2.5. Methods We collected data from prior studies on the association of PM2.5 with CKD and used an integrative meta-regression approach to build non-linear exposure-response models of the risk of CKD associated with PM2.5 exposure. We then estimated the 2017 global and national incidence, prevalence, disability-adjusted life-years (DALYs) and deaths due to CKD attributable to PM2.5 in 194 countries and territories. Burden estimates were generated by linkage of risk estimates to Global Burden of Disease study datasets. Results The exposure-response function exhibited evidence of an increase in risk with increasing PM2.5 concentrations, where the rate of risk increase gradually attenuated at higher PM2.5 concentrations. Globally, in 2017, there were 3 284 358.2 (95% UI 2 800 710.5 to 3 747 046.1) incident and 122 409 460.2 (108 142 312.2 to 136 424 137.9) prevalent cases of CKD attributable to PM2.5, and 6 593 134.6 (5 705 180.4 to 7 479 818.4) DALYs and 211 019.2 (184 292.5 to 236 520.4) deaths due to CKD attributable to PM 2.5. The burden was disproportionately borne by low income and lower middle income countries and exhibited substantial geographic variability, even among countries with similar levels of sociodemographic development. Globally, 72.8% of prevalent cases of CKD attributable to PM2.5 and 74.2% of DALYs due to CKD attributable to PM2.5 were due to concentrations above 10 mu g/m(3), the WHO air quality guidelines. Conclusion The global burden of CKD attributable to PM2.5 is substantial, varies by geography and is disproportionally borne by disadvantaged countries. Most of the burden is associated with PM2.5 levels above the WHO guidelines, suggesting that achieving those targets may yield reduction in CKD burden.This publication has 63 references indexed in Scilit:
- Ambient Air Pollution Exposure Estimation for the Global Burden of Disease 2013Environmental Science & Technology, 2015
- Basic mechanisms for adverse cardiovascular events associated with air pollutionHeart, 2014
- Subchronic effects of inhaled ambient particulate matter on glucose homeostasis and target organ damage in a type 1 diabetic rat modelToxicology and Applied Pharmacology, 2014
- An Integrated Risk Function for Estimating the Global Burden of Disease Attributable to Ambient Fine Particulate Matter ExposureEnvironmental Health Perspectives, 2014
- Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic reviewBMC Public Health, 2013
- Greater variability in kidney function is associated with an increased risk of deathKidney International, 2012
- Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney®ScoresBMC Family Practice, 2010
- Diesel Exhaust Particles in the Lung Aggravate Experimental Acute Renal FailureToxicological Sciences, 2009
- A Quality-Effects Model for Meta-AnalysisEpidemiology, 2008
- Association between Smoking and Chronic Renal Failure in a Nationwide Population-Based Case-Control StudyJournal of the American Society of Nephrology, 2004